Suppression of T-cell alloreactivity by gene-therapeutic modulation of human dendritic stimulator cells with TGF-beta adenoviral vectors.
Institute of Immunology, Department of Transplantation Immunology, University of Heidelberg, Heidelberg, Germany. christoph_dufter@med.uni-heidelberg.de
C
C
Dufter
A
A
Watzlik
C
C
Christ
M
M
Jung
A
A
Wirzbach
G
G
Opelz
P
P
Terness
D000256:Adenoviridae; D002460:Cell Line; D003713:Dendritic Cells / Q000276:immunology* / Q000637:transplantation / Q000821:virology; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000627:therapeutic use*; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000235:genetics*; D023001:Transplantation Tolerance / Q000276:immunology*
D016212:Transforming Growth Factor beta